Skip to main content

Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.

Publication ,  Journal Article
Pun, PH; Parzynski, CS; Friedman, DJ; Sanders, G; Curtis, JP; Al-Khatib, SM
Published in: Clin J Am Soc Nephrol
November 6, 2020

BACKGROUND AND OBJECTIVES: Patients on dialysis are at high risk of complications related to implantable cardioverter defibrillator (ICD) implantation; use of subcutaneous ICDs may be preferred over transvenous devices due to lower risk of bloodstream infection and interference with vascular access sites. We evaluated trends in use and in-hospital outcomes of subcutaneous compared with transvenous ICDs among patients on dialysis in the United States. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Retrospective analysis of ICD implants from 2012 to 2018 among patients on dialysis reported to the National Cardiovascular Data Registry ICD Registry, a nationally representative US ICD Registry. We examined overall trends in subcutaneous ICD adoption as a proportion of all eligible ICD implants among patients on dialysis and then compared in-hospital outcomes between eligible subcutaneous ICD and transvenous ICD recipients using inverse probability of treatment weighting. RESULTS: Of the 23,136 total ICD implants in patients on dialysis during the study period, 3195 (14%) were subcutaneous ICDs. Among eligible first-time ICD recipients on dialysis, the proportion of subcutaneous ICDs used increased yearly from 10% in 2012 to 69% in 2018. In propensity score-weighted analysis of 3327 patients, compared with transvenous ICDs, patients on dialysis receiving subcutaneous ICDs had a higher rate of in-hospital cardiac arrest (2% versus 0.4%, P=0.002), but there was no significant difference in total in-hospital complications (2% versus 1%, P=0.08), all-cause death, or length of hospital stay. CONCLUSIONS: The utilization of subcutaneous ICDs among US patients on dialysis has been steadily increasing. The overall risk of short-term complications is low and comparable with transvenous ICDs, but higher risks of in-hospital cardiac arrest merits closer monitoring and further investigation. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_09_23_CJN07920520.mp3.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin J Am Soc Nephrol

DOI

EISSN

1555-905X

Publication Date

November 6, 2020

Volume

15

Issue

11

Start / End Page

1622 / 1630

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • United States
  • Time Factors
  • Retrospective Studies
  • Renal Dialysis
  • Registries
  • Prosthesis Implantation
  • Postoperative Complications
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pun, P. H., Parzynski, C. S., Friedman, D. J., Sanders, G., Curtis, J. P., & Al-Khatib, S. M. (2020). Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis. Clin J Am Soc Nephrol, 15(11), 1622–1630. https://doi.org/10.2215/CJN.07920520
Pun, Patrick H., Craig S. Parzynski, Daniel J. Friedman, Gillian Sanders, Jeptha P. Curtis, and Sana M. Al-Khatib. “Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.Clin J Am Soc Nephrol 15, no. 11 (November 6, 2020): 1622–30. https://doi.org/10.2215/CJN.07920520.
Pun PH, Parzynski CS, Friedman DJ, Sanders G, Curtis JP, Al-Khatib SM. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis. Clin J Am Soc Nephrol. 2020 Nov 6;15(11):1622–30.
Pun, Patrick H., et al. “Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.Clin J Am Soc Nephrol, vol. 15, no. 11, Nov. 2020, pp. 1622–30. Pubmed, doi:10.2215/CJN.07920520.
Pun PH, Parzynski CS, Friedman DJ, Sanders G, Curtis JP, Al-Khatib SM. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis. Clin J Am Soc Nephrol. 2020 Nov 6;15(11):1622–1630.

Published In

Clin J Am Soc Nephrol

DOI

EISSN

1555-905X

Publication Date

November 6, 2020

Volume

15

Issue

11

Start / End Page

1622 / 1630

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • United States
  • Time Factors
  • Retrospective Studies
  • Renal Dialysis
  • Registries
  • Prosthesis Implantation
  • Postoperative Complications
  • Middle Aged
  • Male